beta
Trial Radar AI

Showing clinical trials matching location: Italy.

I can help you find nearby clinical trials and understand health conditions and treatments.
13 Results
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Location
Italy
×
 
Age Group
Older Adult
×
 
Intervention
GLP-1
×
 
Study Title
Status
Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment (MYO-PRESERVE) NCT07393360
Recruiting
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM (STABLE-GLP1) NCT07314684
Recruiting
Food (poly)phenol Metabotypes and Beta-cell Mass and Function. (META-BETA) NCT06888167
Recruiting
Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus NCT05662189
Recruiting
Effects of VLCKD in Metabolic Syndrome (KETO-MI) NCT05275608
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) NCT07165028
Recruiting
Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. (STARS extend) NCT05018286
Active, not recruiting
Fibrosis Lessens After Metabolic Surgery (FLAMES) NCT06374875
Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study (COMMIT-UC) NCT06937086
Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight (COMMIT-CD) NCT06937099
Recruiting
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight (SURPASS-T1D-1) NCT06914895
Active, not recruiting
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO) NCT05556512
Active, not recruiting
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY) NCT05433584
Active, not recruiting